Last updated on July 2020

OLE for Patients Enrolled in Phase 2b/3 Study ANAVEX2-73-AD-004


Brief description of study

This is a Phase 2b/3 open-label extension study to evaluate the effects of ANAVEX2-73 on safety and effficacy of daily treatment.

Detailed Study Description

This is a Phase 2b/3 open-label extension study to evaluate the effects of ANAVEX2-73 on safety and effficacy of daily treatment.

Clinical Study Identifier: NCT04314934

Find a site near you

Start Over

Sydney

Macquarie Park, Australia
0.81miles
  Connect »

Sydney

Hornsby, Australia
6.18miles
  Connect »

Sydney

Sydney, Australia
7.38miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.